Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Expedited Drug Approval May Push Up Pharmacyclics' Value And Stock Price
Expedited Drug Approval May Push Up Pharmacyclics' Value And Stock Price
Expedited Drug Approval May Push Up Pharmacyclics' Value And Stock Price
Submitted by
admin
on August 12, 2013 - 5:03pm
Source:
Seeking Alpha
News Tags:
Pharmacyclics
ibrutinib
JNJ
chronic lymphocytic leukemia
mantle cell lymphoma
Headline:
Expedited Drug Approval May Push Up Pharmacyclics' Value And Stock Price
Do Not Allow Advertisers to Use My Personal information
